Head-to-head · WeighScore
Nolu vs RX Bella
The verdict
Nolu takes it — 69.7/100 to 67.8/100, but only just.
Nolu grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A wellness-branded compounded GLP-1 seller with an all-in per-order price and an oral semaglutide route — but its "$249" is billed per 4 weeks, not per calendar month. RX Bella is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Nolu | RX Bella |
|---|---|---|
| WeighScore | 69.7/100 | 67.8/100 |
| Grade | C | C |
| Scorecard rank | #133 | #173 |
| Semaglutide | $249/mo injectable, $279/mo oral — billed per 4 weeks | From $249/mo (a floor, not a rate) |
| Tirzepatide | $339/mo — billed per 4 weeks | From $299/mo (a floor, not a rate) |
| Coverage | All 50 states plus Washington, D.C. | Nationwide telehealth, claimed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #133 · C
Strengths
- All-in per-order pricing — consultation, medication and shipping in one figure, no separate membership fee
- Oral semaglutide ($279 per 4 weeks) alongside the injectable, plus a Microdose GLP-1+B12/NAD+ stack ($179 per 4 weeks)
- LegitScript verified, available in all 50 states plus Washington, D.C.
Where it loses points
- Billed "per 4 weeks" rather than calendar month — roughly 8% higher annualized than the $249/$339 headline implies
- No named medical director, prescribers, or compounding pharmacy disclosed anywhere on the site
- Compounded only — not the FDA-approved brand product (Wegovy/Ozempic), which matters if you're relying on insurance
Graded #173 · C
Strengths
- All four programs — microdose, oral, semaglutide injection, tirzepatide injection — carry a figure on the homepage before any intake
- Nothing in the catalog is struck through: no invented "was" price and no expiring offer
- "$0 if you're not approved" is stated plainly and repeatedly
- The online provider visit, prescription, delivery and ongoing check-ins are stated as included
Where it loses points
- The hero's "from $199/mo" is the microdose; the tirzepatide program is $299
- Every figure is a floor, no dose ladder is published, and the eight-screen intake reaches an email gate without showing a price
- Its own treatment pages carry no dollar figure and read "AVAILABLE BY CONSULTATION"
- No lab or monitoring requirement is published
- The compounding pharmacies are never named and the footer names no company
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.